Patent ID: 9241956
Filing Date: 2016-01-26
CPC Classification: A61K

Claim Text:
1. A method for the treatment of diabetes in mammals and humans, comprising administering to a host in need thereof a therapeutically effective amount of a pharmaceutical composition to be used as an oral medication, wherein the pharmaceutical composition comprises: a) an antacid agent; b) a composition for treatment of diabetes; c) a first enteric coating; and d) a second enteric coating; wherein the antacid agent is coated by the first enteric coating, such that a plurality of individual pellets is embedded in the antacid agent, such that each pellet contains an amount of the composition for treatment of diabetes inside a coating of the second enteric coating, such that a total amount of the composition for treatment of diabetes aggregates to a pharmaceutically effective amount; wherein the first enteric coating is configured to dissolve immediately upon entry to the small intestine, such that the antacid agent is delivered immediately upon entry of the small intestine; wherein the second enteric coating is configured for extended release, such that the composition for treatment of diabetes is delivered according to an extended release predetermined delivery distribution, whereby the composition for treatment of diabetes is delivered across a predetermined segment of the small intestine; whereby the pharmaceutical composition upon oral ingestion in the host is delivered to the small intestine, and thereby reduces acidity, increasing the pH level of the small intestine, whereby the antacid agent in conjunction with the composition for treatment of diabetes effectuates a lowering of blood sugar levels of the host.